about
Alternative RNA splicing: contribution to pain and potential therapeutic strategyP2X ion channel receptors and inflammationHematopoietic pannexin 1 function is critical for neuropathic painSynaptic studies inform the functional diversity of cochlear afferentsAntipurinergic therapy corrects the autism-like features in the Fragile X (Fmr1 knockout) mouse model.Resveratrol-decreased hyperalgesia mediated by the P2X7 receptor in gp120-treated ratsAlpha-lipoic Acid suppresses P2X receptor activities and visceral hypersensitivity to colorectal distention in diabetic rats.P2X receptors: New players in cancer pain.Haplotypes of P2RX7 gene polymorphisms are associated with both cold pain sensitivity and analgesic effect of fentanyl.B-type natriuretic peptide-induced delayed modulation of TRPV1 and P2X3 receptors of mouse trigeminal sensory neurons.P2X₇ receptor of rat dorsal root ganglia is involved in the effect of moxibustion on visceral hyperalgesia.Regulation of Neurotrophin-3 and Interleukin-1β and Inhibition of Spinal Glial Activation Contribute to the Analgesic Effect of Electroacupuncture in Chronic Neuropathic Pain States of Rats.Microencapsulation improves inhibitory effects of transplanted olfactory ensheathing cells on pain after sciatic nerve injury.Photobiomodulation therapy reduces apoptotic factors and increases glutathione levels in a neuropathic pain model.Differential expression of ATP-gated P2X receptors in DRG between chronic neuropathic pain and visceralgia rat models.Modulation of P2X3 and P2X2/3 Receptors by Monoclonal AntibodiesEXPRESS: NGF-trkA signaling modulates the analgesic effects of prostatic acid phosphatase in resiniferatoxin-induced neuropathy.Structural basis for subtype-specific inhibition of the P2X7 receptor.P2X3 and P2X2/3 receptor antagonists.The role of purinergic signaling in the etiology of migraine and novel antimigraine treatment.Silencing of P2X7R by RNA interference in the hippocampus can attenuate morphological and behavioral impact of pilocarpine-induced epilepsy.Short- and long-term (trophic) purinergic signalling.Moist heat or dry heat for delayed onset muscle soreness.Dura-evoked neck muscle activity involves purinergic and N-methyl-D-aspartate receptor mechanisms.Molecular mechanism for opioid dichotomy: bidirectional effect of μ-opioid receptors on P2X₃ receptor currents in rat sensory neurones.P2X3 receptor involvement in endometriosis pain via ERK signaling pathway.Phenotypic changes in dorsal root ganglion and spinal cord in the collagen antibody-induced arthritis mouse model.Sympathetic fibre sprouting in the skin contributes to pain-related behaviour in spared nerve injury and cuff models of neuropathic pain.Stable, synthetic analogs of diadenosine tetraphosphate inhibit rat and human P2X3 receptors and inflammatory painP2Y12 receptor upregulation in satellite glial cells is involved in neuropathic pain induced by HIV glycoprotein 120 and 2',3'-dideoxycytidine.The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression.Electroacupuncture and A-317491 depress the transmission of pain on primary afferent mediated by the P2X3 receptor in rats with chronic neuropathic pain states.Nanoparticle-Encapsulated Curcumin Inhibits Diabetic Neuropathic Pain Involving the P2Y12 Receptor in the Dorsal Root Ganglia.Diverse effects of Brilliant Blue G administration in models of trigeminal activation in the rat.Effects of intermedin on dorsal root ganglia in the transmission of neuropathic pain in chronic constriction injury rats.Andrographolide Inhibits Mechanical and Thermal Hyperalgesia in a Rat Model of HIV-Induced Neuropathic Pain.Activation of the P2X receptor in midbrain periaqueductal gray participates in the analgesic effect of tramadol in bone cancer pain rats
P2860
Q26744085-2C319CAC-8A90-452D-BF91-8BDF173D4D4CQ28066934-289E0110-BD5A-48A3-853E-00557124C2EFQ30274778-CA0AD17A-9E03-496E-9C5D-F52770C5593CQ30368629-07626735-1D9B-48AD-A22E-2F35B8BDC1F3Q30418368-E3474E20-B99F-4442-A6A7-FC3343544451Q33752131-82551382-E208-4CFC-B6F5-F20E3DD1EF49Q33849181-5221C5E2-2B62-4B92-887A-9C09A13136CFQ34567944-A07B284B-A3E0-4FD2-B870-9B504ECD5A4BQ34695004-18BCB120-D825-4C39-AEE0-2D3FB9D293DFQ35060436-91294B04-477E-4ACB-9DFC-412569DC84BAQ35587841-A1C6D9C0-DFAA-4E18-AC9D-07216DA90CE1Q35805686-4BB4F16B-2F76-4D4F-9E45-4E45A9B6ADA2Q35815660-5B1BCD54-BC21-424D-B7A7-5A9850E83A35Q36136505-53A7AA98-A4BC-4A05-AAA4-4551801511B8Q36568417-6B521A9D-3A49-4E52-A65F-23B63B0C67C9Q37066034-F482EF9B-6B72-41BA-BE9C-DF8CB9DAD9FBQ37114795-7166D9A5-6B91-4110-8474-7A10B5B14D8BQ37524867-6C475B33-99B9-4C9D-AEF6-F3992725C9C3Q38172655-605EBB81-3323-4FC6-9E61-887943985FC5Q38468977-0F086A0F-2DDD-41E9-A699-4621F74BD66FQ38679789-622F4164-9C2B-44E7-BF40-F8F7A72A7240Q38885851-084C5A25-A5CE-492E-A181-1EA498FD8C91Q39218098-6FDB7B18-A7AD-4F50-9773-26E6B3238867Q40331538-AD2F22AF-4FC4-480E-833C-F367703044ADQ40479525-A480B0AD-F60F-4143-B0E4-20201EAE4767Q41227822-A9C1B3B9-301F-4DDC-BF00-5265756CA513Q41511566-0DF76AFA-33DE-412F-9B98-A62168CBC091Q42242056-3B8CACA2-9450-4725-915B-C5B811D4E0ADQ42409253-DAA670AE-7801-455F-B954-242AF3D91954Q47380119-0A29A11A-1D64-4317-9697-C8C8A37EFC52Q47571865-70339A9F-EB68-4B11-A07C-A9FA06FFF81BQ47840354-E04ACE92-B8D4-4610-B959-06637F0E5359Q49816634-B0F28F05-F4ED-4B90-8E94-B7EA32F71A81Q50210809-3D50252A-6430-4AE2-9122-ABA07EC70575Q54163600-AE948DDB-F463-4535-815D-ED6AB4794DD4Q55285468-160BE44B-94FD-4C9B-8C20-A9693B2E84FBQ58752914-D1042526-031D-4DA0-8BC8-58DE1A515868
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Purinergic mechanisms and pain--an update.
@ast
Purinergic mechanisms and pain--an update.
@en
Purinergic mechanisms and pain--an update.
@nl
type
label
Purinergic mechanisms and pain--an update.
@ast
Purinergic mechanisms and pain--an update.
@en
Purinergic mechanisms and pain--an update.
@nl
prefLabel
Purinergic mechanisms and pain--an update.
@ast
Purinergic mechanisms and pain--an update.
@en
Purinergic mechanisms and pain--an update.
@nl
P1476
Purinergic mechanisms and pain--an update.
@en
P2093
Geoffrey Burnstock
P356
10.1016/J.EJPHAR.2013.01.078
P407
P577
2013-03-22T00:00:00Z